reference/12155568

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12155568

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, N.I.H., Intramural\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	4730
issn	1538-7445 0008-5472
issueIdentifier	16
pageRange	4716-4730
publicationName	Cancer Research
startingPage	4716
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_03c9b527acc5cffad34e448eba1b64ee http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2f1f5a3920787349e896f76286119f3a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_969ccf6fe026f2f48265f62ea5c814c6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_35800c05893d328af9fbf806f7b91e86 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d62f51386142d8e7576b9b70134d6e59 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4c4f4a6c5972ec75e3fd979c7098e660 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5e4651ddb1e2085b46c23e16f1148a9b
bibliographicCitation	Sowalsky AG, Ye H, Bhasin M, Van Allen EM, Loda M, Lis RT, Montaser-Kouhsari L, Calagua C, Ma F, Russo JW, Schaefer RJ, Voznesensky OS, Zhang Z, Bubley GJ, Montgomery B, Mostaghel EA, Nelson PS, Taplin ME, Balk SP. Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations. Cancer Res. 2018 Aug 15;78(16):4716–30. PMID: 29921690; PMCID: PMC6095796.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d08bf03834d16555394b5f04e90c569f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_843ffb2a0dc014e35e25ac17ccd3be6c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c75257d8a4e60bf887caac241d722ecd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf0d37dd3cc005720b037e943a10f1ae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80e9e5e724ef26bce75ad11dbc79bdba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c3628354c14d08d042323b3cdd0fae6b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5f85d801dcf389a6acae1e1fc4af2c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2760-1853 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0228db21ab90786bfaec417a4e03b89 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_564f5b65e03b6143ce2f1564b7da6192 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0af11f3dc7a3b14d48e06372af05e759 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d803c5374369c9f91d29e7d2278999e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6490ad073cb5d4e222764c3b8cf7cd1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e6f0e2f2d6020e3f1b9889c0d753f0f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_408127993cf1d3f13fac770fd8082c5f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d40b9a0d9c10f4bb7e5c81711e57be0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbae2aebb832719240406a4728401800 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9c5dd40001722d62214bdeb75db18fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3088dac1a696393e5241fffc765b9b9a
date	2018-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/29921690 https://doi.org/10.1158/0008-5472.can-18-0610 https://pubmed.ncbi.nlm.nih.gov/PMC6095796
isPartOf	https://portal.issn.org/resource/ISSN/0008-5472 https://portal.issn.org/resource/ISSN/1538-7445 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2786
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations
discusses	http://id.nlm.nih.gov/mesh/M0018556 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0562608 http://id.nlm.nih.gov/mesh/M0418489 http://id.nlm.nih.gov/mesh/M0001774 http://id.nlm.nih.gov/mesh/M0001103 http://id.nlm.nih.gov/mesh/M0073493 http://id.nlm.nih.gov/mesh/M000617183
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D064129Q000188 http://id.nlm.nih.gov/mesh/D009364Q000188 http://id.nlm.nih.gov/mesh/D019008Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D014408 http://id.nlm.nih.gov/mesh/D000072467Q000235 http://id.nlm.nih.gov/mesh/D020360 http://id.nlm.nih.gov/mesh/D064129Q000473 http://id.nlm.nih.gov/mesh/D039181Q000235 http://id.nlm.nih.gov/mesh/D009364Q000235 http://id.nlm.nih.gov/mesh/D064129Q000235 http://id.nlm.nih.gov/mesh/D063646 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D009364Q000473 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011468 http://id.nlm.nih.gov/mesh/D060965 http://id.nlm.nih.gov/mesh/D000726Q000008 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D001189Q000235 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011944Q000235 http://id.nlm.nih.gov/mesh/D000069501Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10251 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9455a7be1a7c0dbb6de4ba8898dff00c http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9821849 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657181 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431

Total number of triples: 89.